Home/Filings/4/0001209191-22-054287
4//SEC Filing

NEA Partners 15, L.P. 4

Accession 0001209191-22-054287

CIK 0001325879other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 4:44 PM ET

Size

16.2 KB

Accession

0001209191-22-054287

Insider Transaction Report

Form 4
Period: 2022-10-19
Transactions
  • Other

    Common Stock

    2022-10-193,952,9570 total(indirect: See Note 4)
  • Other

    Common Stock

    2022-10-19+3,952,9573,952,957 total(indirect: See Note 4)
  • Other

    Common Stock

    2022-10-19+59,29459,294 total
  • Other

    Common Stock

    2022-10-1959,2940 total
  • Other

    Common Stock

    2022-10-193,952,9570 total(indirect: See Note 2)
Transactions
  • Other

    Common Stock

    2022-10-193,952,9570 total(indirect: See Note 2)
  • Other

    Common Stock

    2022-10-19+59,29459,294 total
  • Other

    Common Stock

    2022-10-193,952,9570 total(indirect: See Note 4)
  • Other

    Common Stock

    2022-10-19+3,952,9573,952,957 total(indirect: See Note 4)
  • Other

    Common Stock

    2022-10-1959,2940 total
Footnotes (8)
  • [F1]Growth Equity Opportunities Fund IV, LLC ("GEO IV") made a distribution of 3,952,957 shares of Common Stock of the Issuer to its sole member for no consideration on October 19, 2022.
  • [F2]The securities are directly held by GEO IV, and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the "NEA 15 Managers"), together, the "GEO IV Indirect Reporting Persons"). The NEA 15 Managers are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell and Peter W. Sonsini. The GEO IV Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities in which the GEO IV Indirect Reporting Persons have no pecuniary interest.
  • [F3]NEA 15 received 3,952,957 shares of Common Stock of the Issuer in the distribution made by GEO IV on October 19, 2022.
  • [F4]The securities are directly held by NEA 15 and are indirectly held by NEA Partners 15, the sole general partner of NEA 15, NEA 15 GP, the sole general partner of NEA Partners 15, and the NEA 15 Managers (NEA Partners 15, NEA 15 GP and the NEA 15 Managers, together, the "NEA 15 Indirect Reporting Persons"). The NEA 15 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the NEA 15 Indirect Reporting Persons have no pecuniary interest.
  • [F5]NEA 15 made a pro rata distribution of 3,952,957 shares of Common Stock of the Issuer for no consideration to its general partner and limited partners on October 19, 2022.
  • [F6]NEA Partners 15 received 59,294 shares of Common Stock of the Issuer in the distribution made by NEA 15 on October 19, 2022.
  • [F7]The securities are directly held by NEA Partners 15 and indirectly held by NEA 15 GP, the sole general partner of NEA Partners 15, and the NEA 15 Managers (NEA 15 GP and the NEA 15 Managers together, the "NEA Partners 15 Indirect Reporting Persons"). The NEA Partners 15 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 15 in which the NEA Partners 15 Indirect Reporting Persons have no pecuniary interest.
  • [F8]NEA Partners 15 made a pro rata distribution for no consideration of an aggregate of 59,294 shares of Common Stock of the Issuer to its limited partners on October 19, 2022.

Issuer

AVEO PHARMACEUTICALS, INC.

CIK 0001325879

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001640031

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:44 PM ET
Size
16.2 KB